SEC Form 4 · accession 0001179110-15-007644
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dorothy E Puhy
Director
Period of report
May 8, 2015
Accepted (ET)
May 12, 2015 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par valueF1,F4 | May 8, 2015 | S | 864 | $64.1598 | D | 68,940 | D | |
| Common Stock, $0.01 par valueF1,F5 | May 8, 2015 | S | 971 | $65.1291 | D | 67,969 | D | |
| Common Stock, $0.01 par valueF1,F6 | May 8, 2015 | S | 510 | $66.3304 | D | 67,459 | D | |
| Common Stock, $0.01 par valueF1,F7 | May 8, 2015 | S | 1,301 | $67.3336 | D | 66,158 | D | |
| Common Stock, $0.01 par valueF1,F8 | May 8, 2015 | S | 737 | $67.8776 | D | 65,421 | D | |
| Common Stock, $0.01 par valueF1,F9 | May 8, 2015 | S | 174 | $69.0306 | D | 65,247 | D | |
| Common Stock, $0.01 par valueF1,F10 | May 8, 2015 | S | 19 | $69.8099 | D | 65,228 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F11 | $13.21 | holding | — | — | — | Aug 8, 2007 | Aug 9, 2016 | Common Stock | 8,000 | 8,000 | D |
| Stock option (right to buy)F2,F11 | $12.69 | holding | — | — | — | Aug 13, 2008 | Aug 8, 2017 | Common Stock | 8,000 | 8,000 | D |
| Stock Option (right to buy)F3,F11 | $18.63 | holding | — | — | — | Aug 12, 2009 | Aug 13, 2018 | Common Stock | 13,500 | 13,500 | D |
| Stock Option (right to buy)F3,F11 | $7.67 | holding | — | — | — | Aug 11, 2010 | Aug 12, 2019 | Common Stock | 13,500 | 13,500 | D |
| Stock Option (right to buy)F3,F11 | $9.99 | holding | — | — | — | Aug 10, 2011 | Aug 11, 2020 | Common Stock | 13,500 | 13,500 | D |
Explanation of responses
- F1Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- F10This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.7000 and $69.9600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F11This option becomes exerciseable in full on the date set forth in Table II, Column 6.
- F2Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- F3Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F4This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $63.6200 and $64.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $64.6200 and $65.6100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $65.6750 and $66.6500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $66.7000 and $67.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F8This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $67.7000 and $68.6600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F9This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $68.7000 and $69.6900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.